19 results
8-K
EX-2.2
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.4
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.3
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
LSTA
Lisata Therapeutics Inc
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-2.1
LSTA
Lisata Therapeutics Inc
17 Mar 17
Support Agreement and Irrevocable Proxy
12:00am
DEFA14A
EX-2.1
0lkxq x00dg8p
17 Mar 17
Additional proxy soliciting materials
12:00am
DEFA14A
EX-2.1
a5gc8dgo5cdrve9exa
17 Mar 17
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
q62 khbv2wc2wtjr2jh
17 Mar 17
Support Agreement and Irrevocable Proxy
12:00am
8-K
EX-2.1
y2v1pldza36r 5oq
14 Apr 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
3a2qxyok4xdp1rlskki
24 Aug 12
Entry into a Material Definitive Agreement
12:00am
DEFA14A
EX-2.1
5ploj
18 Jun 12
Additional proxy soliciting materials
12:00am
8-K
EX-2.1
ofch 46v2
18 Jun 12
NeoStem Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye
12:00am
8-K
EX-2.1
hy3s5m4iry ocrkq
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
j8jlx
14 Jul 11
Business combination disclosure
12:00am
425
EX-2.1
ywmi7ah
23 Sep 10
Business combination disclosure
12:00am
8-K
EX-2.1
tpuh37v57oq7lb3at7
23 Sep 10
NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
12:00am
8-K
EX-2.1
7ci65hw icmdl1ts3vu
6 Nov 08
NeoStem Signs Definitive Agreement to Acquire Controlling Interest in a Leading Chinese Pharmaceutical Company
12:00am
8-K
EX-2.1
pnotvzcg4pq1fzf
6 Nov 08
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next